Member Info for Borsaci06

just found this on twitter.

@tenbagger8
#MTPH - Midatech Pharma
It seems that Secura Bio are currently performing a phase I study of Marizomib + Panobinostat for Children With DIPG:
https://clinicaltrials.gov/ct2/show/NCT04341311
They acquired the global rights for Farydak (Panobinostat) from Novartis.

https://twitter.com/tenbagger8/status/1272204490582753280

and that`s why trying to cancel the licence.

mtph must be aware of this trail
&
should have taken necessary steps

The following tells me that MTPH got global licence for Panobinostat.
If so, how/where Secura Bio got this FARYDAK® (panobinostat) capsules 10/15/20mg

https://us.farydak.com/

06/07/2017 | 10:05am BST

7 June 2017
Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, today announces that it has signed a global licensing agreement with Novartis for the oncology compound panobinostat.

https://www.marketscreener.com/MIDATECH-PHARMA-PLC-19157045/news/Midatech-Pharma-signs-global-agreement-for-panobinostat-24554089/

this is from trail

Sponsor:
Dana-Farber Cancer Institute

Collaborators:
Celgene
Secura Bio

Information provided by (Responsible Party):
Katherine Warren, MD, Dana-Farber Cancer Institute

Endometriosis and in vitro fertilisation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090275/

Womens Health
https://womenshealth.annualcongress.com/events-list/endometriosis

Japan’s deputy prime minister blames childless women for declining population
https://www.channel3000.com/japans-deputy-prime-minister-blames-childless-women-for-declining-population/

Global Endometriosis Industry
have look at this website
you`ll notice Val in that list as well as big players including some from japan
https://www.prnewswire.com/news-releases/global-endometriosis-industry-300781472.html

Minnissage
you got very good bet there.

Val said in RNS:
"" while the Japanese Company has a range of pre-clinical assays for testing drug candidates for use in the treatment of endometriosis, as well as several commercial and developmental products in women's health, and other healthcare areas ""

following from their ( Shionogi ) website

WOMEN’S HEALTH
To improve women’s health, we developed a therapy for post-menopausal vulvar and vaginal atrophy - a condition in which declining oestrogen levels have adversely affected the thickness of vaginal epithelial cells, elasticity and vaginal secretion
https://www.shionogi.com/eu/en/innovation/our-areas-of-focus.html

here you go if you are lazy
https://clinicaltrials.gov/ct2/show/NCT04341311

so far 10 filings today

did anyone managed to find out the name of Undisclosed Japanese Pharmaceutical Company ?

if this is our Panobinostat
how come Secura Bio recruiting for this trial
Last Update Posted : August 11, 2020

they said licence terminated
https://dipg.org/dipg-treatment/active-clinical-trials/

negativity about VAL should be in the past. maybe except CFO

I had started wearing Pink tinted glasses just before GM kicked out by the good guys/girls here + some help from outside
everybody sells at some point afterall it is a investment with R:R whether day trader or not

repurposed compound is same/unchanged
+
BC201

future is bright
imho

in my humble opinion

each to their own

resedent poster/s not happy;
val changed, sp doing what is supposed to

why keep suffering & spreading sorrow
sell off
come back if/when happy enough

val201 + bc201

with one product targeting
not only Prostate Cancer but also Covid-19
what`s not to like

some people love to jinx

that`s what I am saying.
if exercised @ 15p
that may show warrant holders betting for positive news
and bods well with me

when exercised just over 15p
planing to sell into news/rise/spike
still risky
imho